Heparan sulfate proteoglycans retain Noggin at the cell surface - A potential mechanism for shaping bone morphogenetic protein gradients

被引:177
作者
Paine-Saunders, S
Viviano, BL
Economides, AN
Saunders, S
机构
[1] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA
[2] St Louis Childrens Hosp, St Louis, MO 63110 USA
[3] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA
[4] Washington Univ, Sch Med, Dept Biol & Pharmacol, St Louis, MO 63110 USA
关键词
D O I
10.1074/jbc.M109151200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bone morphogenetic proteins (BMPs) are expressed broadly and regulate a diverse array of developmental events in vivo. Essential to many of these functions is the establishment of activity gradients of BMP, which provide positional information that influences cell fates. Secreted polypeptides, such as Noggin, bind BMPs and inhibit their function by preventing interaction with receptors on the cell surface. These BNIP antagonists are assumed to be diffusible and therefore potentially important in the establishment of BNIP activity gradients in vivo. Nothing is known, however, about the potential interactions between Noggin and components of the cell surface or extracellular matrix that might limit its diffusion. We have found that Noggin binds strongly to heparin in vitro, and to heparan sulfate proteoglycans on the surface of cultured cells. Noggin is detected only on the surface of cells that express heparan sulfate, can be specifically displaced from cells by heparin, and can be directly cross-linked to a cell surface proteoglycan in culture. Heparan sulfate-bound Noggin remains functional and can bind BMP4 at the plasma membrane. A Noggin mutant with a deletion in a putative heparin binding domain has reduced binding to heparin and does not bind to the cell surface but has preserved BMP binding and antagonist functions. Our results imply that interactions between Noggin and heparan sulfate proteoglycans in vivo regulate diffusion and therefore the formation of gradients of BMP activity.
引用
收藏
页码:2089 / 2096
页数:8
相关论文
共 41 条
  • [1] The bone morphogenetic proteins antagonist noggin inhibits membranous ossification
    Aspenberg, P
    Jeppsson, C
    Economides, AN
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (03) : 497 - 500
  • [2] The organizer factors Chordin and Noggin are required for mouse forebrain development
    Bachiller, D
    Klingensmith, J
    Kemp, C
    Belo, JA
    Anderson, RM
    May, SR
    McMahon, JA
    McMahon, AP
    Harland, RM
    Rossant, J
    De Robertis, EM
    [J]. NATURE, 2000, 403 (6770) : 658 - 661
  • [3] Baeg GH, 2001, DEVELOPMENT, V128, P87
  • [4] Functions of cell surface heparan sulfate proteoglycans
    Bernfield, M
    Götte, M
    Park, PW
    Reizes, O
    Fitzgerald, ML
    Lincecum, J
    Zako, M
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 : 729 - 777
  • [5] Is chordin a long-range- or short-range-acting factor?: Roles for BMP1-related metalloproteases in chordin and BMP4 autofeedback loop regulation
    Blitz, IL
    Shimmi, O
    Wünnenberg-Stapleton, K
    O'Connor, MB
    Cho, KWY
    [J]. DEVELOPMENTAL BIOLOGY, 2000, 223 (01) : 120 - 138
  • [6] LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN ALPHA-2-MACROGLOBULIN RECEPTOR IS AN HEPATIC RECEPTOR FOR TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    BU, GJ
    WILLIAMS, S
    STRICKLAND, DK
    SCHWARTZ, AL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) : 7427 - 7431
  • [7] A gradient of BMP activity specifies dorsal-ventral fates in early Xenopus embryos
    Dale, L
    Wardle, FC
    [J]. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 1999, 10 (03) : 319 - 326
  • [8] Dosch R, 1997, DEVELOPMENT, V124, P2325
  • [9] ECONOMIDES AN, 2000, Patent No. 6075007
  • [10] ANIMAL-CELL MUTANTS DEFECTIVE IN GLYCOSAMINOGLYCAN BIOSYNTHESIS
    ESKO, JD
    STEWART, TE
    TAYLOR, WH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (10) : 3197 - 3201